Molecular cloning and characterization of novel human JNK2 (MAPK9) transcript variants that show different stimulation activities on AP-1

BMB Reports

Volumn 43, Issue 11, 2010, Pages 738-743

  Wang, Pingzhang ^a,b,c   Xiong, Ying ^a   Ma, Chuan ^a   Shi, Taiping ^a,b,c   Ma, Dalong ^a,b,c  

^a CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

AP 1; Cloning; JNK2; MAPK9; Transcript variant

Indexed keywords

ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 9; TRANSCRIPTION FACTOR AP 1;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEK293; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HUMAN GENOME; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; PHOSPHORYLATION; SEQUENCE ALIGNMENT;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; CELL PROLIFERATION; CLONING, MOLECULAR; GENE EXPRESSION PROFILING; GENOME, HUMAN; HEK293 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 9; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN ISOFORMS; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTOR AP-1;

MAMMALIA;

EID: 78649761707     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.3858/BMBRep.2010.43.11.738     Document Type: Article

References (20)

1. Weston, C. R. and Davis, R. J. (2007) The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19, 142-149.
2. Dhanasekaran, D. N. and Reddy, E. P. (2008) JNK signaling in apoptosis. Oncogene. 27, 6245-6251.
3. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
4. Bode, A. M. and Dong, Z. (2007) The functional contrariety of JNK. Mol. Carcinog. 46, 591-598.
5. Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Derijard, B. and Davis, R. J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760-2770.
6. Kallunki, T., Su, B., Tsigelny, I., Sluss, H. K., Derijard, B., Moore, G., Davis, R. and Karin, M. (1994) JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8, 2996-3007.
7. Tsuiki, H., Tnani, M., Okamoto, I., Kenyon, L. C., Emlet, D. R., Holgado-Madruga, M., Lanham, I. S., Joynes, C. J., Vo, K. T. and Wong, A. J. (2003) Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors. Cancer Res. 63, 250-255.
8. Dreskin, S. C., Thomas, G. W., Dale, S. N. and Heasley, L. E. (2001) Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells. J. Immunol. 166, 5646-5653.
9. Matlin, A. J., Clark, F. and Smith, C. W. (2005) Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol. 6, 386-398.
10. Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P. and Burge, C. B. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470-476.
11. Wang, P., Yu, P., Gao, P., Shi, T. and Ma, D. (2009) Discovery of novel human transcript variants by analysis of intronic single-block EST with polyadenylation site. BMC Genomics. 10, 518.
12. McGlincy, N. J. and Smith, C. W. (2008) Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense? Trends. Biochem. Sci. 33, 385-393.
13. Kyriakis, J. M. and Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869.
14. Pimienta, G., Ficarro, S. B., Gutierrez, G. J., Bhoumik, A., Peters, E. C., Ronai, Z. and Pascual, J. (2007) Autophosphorylation properties of inactive and active JNK2. Cell Cycle 6, 1762-1771.
15. Cui, J., Holgado-Madruga, M., Su, W., Tsuiki, H., Wedegaertner, P. and Wong, A. J. (2005) Identification of a specific domain responsible for JNK2alpha2 autophosphorylation. J. Biol. Chem. 280, 9913-9920.
16. Jaeschke, A., Karasarides, M., Ventura, J. J., Ehrhardt, A., Zhang, C., Flavell, R. A., Shokat, K. M. and Davis, R. J. (2006) JNK2 is a positive regulator of the cJun transcription factor. Mol. Cell 23, 899-911.
17. Nitta, R. T., Chu, A. H. and Wong, A. J. (2008) Constitutive activity of JNK2 alpha2 is dependent on a unique mechanism of MAPK activation. J. Biol. Chem. 283, 34935-34945.
18. Shaulian, E. and Karin, M. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131-136.
19. Eferl, R. and Wagner, E. F. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868.
20. Wang, P., Shi, T. and Ma, D. (2006) Cloning of a novel human caspase-9 splice variant containing only the CARD domain. Life Sci. 79, 934-940.